Nenning, BB; Christmann, M; Gutjahr, P et al.
Leukämiekranke Kinder - erwachsen geworden.München: Marseille Verlag 2007 0 S.
Guiso, N; Njamkepo, E; Vie le Sage, F et al.
Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of lifeVaccine. Bd. 25. H. 8. 2007 S. 1390-7
Ilkilic, Ilhan; Schmidtke, S.
Medizinethische Aspekte der Kultur in der NeonatologiePädiatrische Praxis. Bd. 70. H. 4. München: Marseille 2007 S. 569 - 576
Grasberger, H; De Deken, X; Miot, F et al.
Missense mutations of dual oxidase 2 (DUOX2) implicated in congenital hypothyroidism have impaired trafficking in cells reconstituted with DUOX2 maturation factor.Mol Endocrinol. Bd. 21. H. 6. 2007 S. 1408-21
Faber, J; Armstrong, SA
Mixed lineage leukemia translocations and a leukemia stem cell programCancer Res. Bd. 67. H. 18. 2007 S. 8425-8
Cybulla, M; Walter, K; Neumann, HP et al.
Morbus Fabry: Demografische Ubersicht seit Einfuhrung der Enzymersatztherapie.Dtsch Med Wochenschr. Bd. 132. H. 28-29. 2007 S. 1505-9
Müller-Forell, WS; Schulze Frenking, G; Amraoui, Y et al.
Mucopolysaccharidoses (MPS) Clinical and neuroradiological aspects of the different typesClinical Neuroradiology. Bd. 17. H. 3. 2007 S. 141-158
Müller-Forell, WS; Schulze Frenking, G; Amraoui, Y et al.
Mucopolysaccharidoses (MPS) Clinical and Neuroradiological Aspects of the different types.Klin Neuroradiol. Bd. 17. 2007 S. 141-158
Karageorgos, L; Brooks, DA; Pollard, A et al.
Mutational analysis of 105 mucopolysaccharidosis type VI patientsHum Mutat. Bd. 28. 2007 S. 897-903
Hoffmann, B; Beck, M; Sunder-Plassmann, G et al.
Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy--a retrospective analysis from the Fabry Outcome Survey.Clin J Pain. Bd. 23. H. 6. 2007 S. 535-42